JNSS 2019, 10(3-4):104-110 | DOI: 10.32725/jnss.2019.012

Secondary prevention of colorectal cancer

Tereza Dušičková*, Sylva Bártlová
University of South Bohemia in České Budějovice, Faculty of Health and Social Sciences, Institute of Nursing, Midwifery and Emergency Care, České Budějovice, Czech Republic

Goal: The goal of this review study is to map the options of secondary prevention of colorectal cancer.

Methods: We used the method of document content analysis. We searched for references using the following keywords: "screening", "colorectal cancer", "occult bleeding", "colonoscopy", and the Boole operators "AND" and "NOT". We used the databases of EBSCO, ProQuest and Pubmed between February and April 2019. After the filtering, we included 20 sources.

Results: The study shows that if colorectal cancer is treated in the early phase, there is a higher probability of survival. We also confirmed a decreased incidence and mortality using the screening of risk groups. The colorectal carcinoma screening is carried out by testing the stool or colonoscopy. To test the stool, we can use haemoccult (gFOBT), immunochemical techniques (FIT) or DNA mutation testing in the stool.

Conclusion: There is not a unanimous recommendation for colorectal carcinoma screening. Some countries have state regulations. This research shows that there is not sufficient proof for using haemoccult tests or immunochemical techniques.

Keywords: Colorectal tumour; Diagnostics; Nurse; Screening; Secondary prevention
Grants and funding:

This article is related to the research grant project No. 048/2015/S "Use of conceptual models in clinical and community practice", which is financially supported by the Grant Agency of the University of South Bohemia in České Budějovice.

Received: May 23, 2019; Accepted: June 6, 2019; Published: September 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dušičková T, Bártlová S. Secondary prevention of colorectal cancer. Journal of Nursing, Social Studies, Public Health and Rehabilitation. 2019;10(3-4):104-110. doi: 10.32725/jnss.2019.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adam Z, Vorlíček J, Vaníček J, et al. (2004). Diagnostické a léčebné postupy u maligních chorob [Diagnostic and therapeutic procedures for malignant diseases]. Praha: Grada (Czech).
    2. Birkenfeld S, Belfer RG, Chared M, Vilkin A, Barchana M, Lifshitz I, et al. (2011). Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. J Med Screen 18(3): 135-141. DOI: 10.1258/jms.2011.010147. Go to original source... Go to PubMed...
    3. Bortlík M (2005). Kolorektální karcinom [Colorectal tumour]. In: Lukáš K et al. (Eds). Gastroenterologie a hepatologie pro zdravotní sestry [Gastroenterology and hepatology for nurses]. Praha: Grada, pp. 195-202 (Czech).
    4. Brenner H, Tao S (2009). Superior diagnostic performance of faceal immunochemical tests for haemoglobin ina head to head comparison with guiac based faecal occult blood tests among 2235 participants of screening colonoscopy. Eur J Cancer 49(14): 3049-3054. DOI: 10.1016/j.ejca.2013.04.023. Go to original source... Go to PubMed...
    5. Bretthauer M, Kaminski MF, Løberg M, Zauber AG, Regula J, Kuipers EJ, et al. (2016). Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Inter Med 176(7): 894-902. DOI: 10.1001/jamainternmed.2016.0960. Go to original source... Go to PubMed...
    6. Chiu HM, Chiu HM, Chang LC, Hsu WF, Chou CK, Wu MS (2015). Non-invasive screening for colorectal cancer in Asia. Best Pract Clin Gastroenterol 29(6): 953-965. DOI: 10.1016/j.bpg.2015.09.015. Go to original source... Go to PubMed...
    7. Chrastina J (2009). Principy testů určených k detekci okultního krvácení do stolice a jejich charakteristika [Principles of tests to detect faecal occult blood and their characteristics]. Interní med 11(4): 193-196 (Czech).
    8. Deutekom M (2010). Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective. Scand J Gastroenterol 45(11): 1345-1349. DOI: 10.3109/00365521.2010.497937. Go to original source... Go to PubMed...
    9. Epidemiologie zhoubných nádorů v České republice [Epidemiology of malignant tumours in the Czech Republic] (2018). [online] [cit. 2019-04-22]. Available from: http://www.svod.cz/ (Czech).
    10. Falt P, Urban O, Suchánek Š, Cyrany J, Bortlík M, Martínek J, et al. (2016). Doporučené postupy České gastroenterologické společnosti ČLS JEP pro diagnostickou a terapeutickou koloskopii [Recommended procedures of the Czech Gastroenterology Society of ČLS JEP for diagnostic and therapeutic coloscopy]. Gastroenterologie a hepatologie 70(6): 523-538. DOI: 10.14735Äamgh2016csgh.info (Czech). Go to original source...
    11. Fraňková S, Synytsya A (2017). Metody diagnózy nádorových onemocnění plic a tlustého střeva [Methods of diagnosis of lung and colon cancer]. Chemické listy 111(8): 502-508 (Czech).
    12. Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH (2010). Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med 50(5-6): 297-299. DOI: 10.1016/j.ypmed.2010.03.010. Go to original source... Go to PubMed...
    13. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC (2010). Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59(1): 62-68. DOI: 10.1136/gut.2009.177089. Go to original source... Go to PubMed...
    14. Holubec L, et al. (2004). Kolorektální karcinom: současné možnosti diagnostiky a léčby [Colorectal carcinoma: current options in diagnosis and treatment]. Praha: Grada (Czech).
    15. Imperiale TF, Ranshoff DF, Itkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. (2014). Multitarget stool DNA testing for colorectal-cancer screening. N Engl. J Med 370: 1287-1297. DOI: 10.1056/NEJMoa1311194. Go to original source... Go to PubMed...
    16. Janíková E, Zeleníková R (2013). Ošetřovatelská péče v chirurgii [Nursing care in surgery]. Praha: Grada (Czech).
    17. Pioche M, Ganne C, Gincul R, De Leusse A, Marsot J, Balique J, et al. (2018). Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial. Endoscopy 50(8): 761-769. DOI: 10.1055/s-0044-100721. Go to original source... Go to PubMed...
    18. Quintero E, Carrillo M, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, et al. (2014). Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology 147(5): 1021-1030. DOI: 10.1053/j.gastro.2014.08.004. Go to original source... Go to PubMed...
    19. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, et al. (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366(8): 697-706. DOI: 10.1056/NEJMoa1108895. Go to original source... Go to PubMed...
    20. Roslani AC, Abdullah T, Arumugam K (2012). Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction. Asian Pac J Cancer Prev 13(1): 237-241. DOI: 10.7314/apjcp.2012.13.1.237. Go to original source... Go to PubMed...
    21. Šachlová M, Májek O (2015). Screening kolorektálního karcinomu [Colorectal cancer screening]. Onkologie 9(4): 162-166 (Czech).
    22. Schneiderová M (2014). Perioperační péče [Perioperative care]. Praha: Grada (Czech).
    23. Segnan N, Patnick J, von Karsa L (2010). European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union.
    24. Seifert B, Májek O, Zavoral M, Král N, Suchánek S, Ngo O, Dušek L (2014). Results of the Czech National Colorectal Cancer Screening Programme - Faecal Occult Blood Tests. Klin Onkol 27(Suppl. 2): 87-97 (Czech). Go to original source...
    25. Shapiro JA, Bobo JK, Church TR, Rex DK, Chovnick G, Thompson TD, et al. (2017). A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol 112(11): 1728-1735. DOI: 10.1038/ajg.2017.285. Go to original source... Go to PubMed...
    26. Skála B (2018). Prevence a screening onkologických onemocnění [Cancer prevention and screening]. Praha: Společnost všeobecného lékařství ČLS JEP (Czech).
    27. Spáčilová Z, Solgajová A, Vörösová G, Zrubcová D (2018). Exogenous risk factors for colorectal cancer in people aged 50 years and older. Kontakt 20(2): 126-133. DOI: 10.1016/j.kontakt.2017.11.005. Go to original source...
    28. Suchánek Š, et al. (2017). Screening kolorektálního karcinomu [Colorectal cancer screening]. In: Špičák J et al. (Eds). Novinky v gastroenterologii a hepatologii II [News in gastroenterology and hepatology]. Praha: Grada, pp. 15-21 (Czech).
    29. Suchánek Š, Vepřeková G, Májek O, Dušek L, Zavoral M (2011). Epidemiologie, etiologie, screening a diagnostika kolorektálního karcinomu, včetně diagnosticko-terapeutických zákroků na tlustém střevě [Epidemiology, etiology, screening and diagnosis of colorectal cancer, including diagnostic-therapeutic interventions in the colon]. Onkologie 5(5): 261-265 (Czech).
    30. Symonds EL, Pedersen S, Cole SR, Massolino J, Byrne D, Guy J, et al. (2015). Improving participation in colorectal cancer screening: a randomised controlled trial of sequential offers of faecal then blood based non-invasive tests. Asian Pac J Cancer Prev 16(18): 8455-8460. DOI: 10.7314/apjcp.2015.16.18.8455. Go to original source... Go to PubMed...
    31. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, et al. (2016). Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement. JAMA 315(23): 2564-2575. DOI: 10.1001/jama.2016.5989. Go to original source... Go to PubMed...
    32. Vyhláška č. 317/2016 Sb., kterou se mění vyhláška č. 70/2012 Sb., o preventivních prohlídkách [Regulation No. 317/2016 Coll., which ammends the regulation No. 70/2012 Coll. on preventative check-ups]. In: Sbírka zákonů České republiky, částka 124/2016, p. 4837 (Czech).
    33. Wang H, Wang P, Liu X, Li L, Xiao X, Liu P, et al. (2019). Factors predicting the colorectal adenoma detection rate in colonoscopic screening of a Chinese population: A prospective study. Medicine (Baltimore) 98(15): e15103. DOI: 10.1097/MD.0000000000015103. Go to original source... Go to PubMed...
    34. Zavoral M, Grega T, Suchánek Š (2016). Komplikace léčby kolorektálního karcinomu [Complications in the treatment of colorectal cancer]. Onkologie 10(1): 41-47 (Czech). Go to original source...
    35. Zikán M, Cibula D (2009). Prevence a screening zhoubných nádorů [Prevention and screening of malignant tumours]. In: Cibula D, Petruželka L, et al. (Eds). Onkogynekologie. Praha: Grada, pp. 93-96 (Czech).
    36. Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. (2015). Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 64(5): 674-690. DOI: 10.1136/gutjnl-2014-307508. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content